<DOC>
	<DOCNO>NCT00447551</DOCNO>
	<brief_summary>Primary objective To evaluate degree correction achievable Sculptra nasolabial fold , mid- low facial volume loss , jawline laxity sign facial age . To document type incidence device-related adverse event Sculptra .</brief_summary>
	<brief_title>Canadian Aesthetic Experience With Sculptra Therapy</brief_title>
	<detailed_description />
	<criteria>Present nasolabial fold , mid lower facial volume loss , jawline laxity sign facial age treat Sculptra The subject must willing able provide write informed consent include release use photographs publication . Subjects refuse photo release eligible participate study . Female subject must postmenopausal least one year hysterectomy tubal ligation ; childbearing potential , must agree use approve method birth control throughout study ( i.e. , oral/systemic contraceptive , intrauterine device ( IUD ) , spermicide combination barrier method contraception ) ; Personal history allergic/anaphylactic reaction , include hypersensitivity local anaesthetic ( lidocaine ) ; Known history bleed disorder ; Active inflammatory process area treat ( skin eruption cyst , pimple , rash , cancerous/precancerous lesion , active skin disease ) ; Active hepatitis within past year ; Subjects pregnant plan become pregnant within study timeframe , breastfeeding ; HIV positive patient ; Recent history trauma face ( &lt; 1 year ) ; Previous use Dermalive Dermadeep ; Previous facial surgery within last six month ; Recent facial filler within last six month ; Planned surgical intervention ( rhinoplasty , facelift , congenital defect repair ) use filler laser initial six month postSculptra therapy ; Subjects clinically important disease judge investigator within 3 month start study ( e.g. , history significant lab abnormality , myocardial infarct , stroke , cancer , connective tissue disease , etc . ) , include subject medical condition might require use immunosuppressive medication trial ( severe asthma , rheumatoid arthritis , organ transplant , etc . ) ; Subjects use superficial dermal resurfacing procedure facial area , include chemical peel , dermabrasion , microderm treatment within six week visit 1 duration main study . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Aesthetic facial volume enhancement</keyword>
</DOC>